Loading…

Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review

Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by a hyperinflammatory state and persistent macrophage activation, resulting in reactive phagocytosis of the hematopoietic elements. In children, it is usually a hereditary disorder, while in adults it is usually acquired secondar...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2020-09, Vol.99 (39), p.e22299-e22299
Main Authors: Mendes, Fernanda Rodrigues, Sobral, Karine Marques, Culler, Hebert Fabricio, Couto, Samuel Campanelli Freitas, Pereira, Juliana, Rocha, Vanderson, Martinez, Gracia Aparecida, Lage, Luís Alberto de Pádua Covas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3557-e44f4e66b6098869fef3e414dc5ca605e8e9dea560d471c990ee64df1b46b6473
container_end_page e22299
container_issue 39
container_start_page e22299
container_title Medicine (Baltimore)
container_volume 99
creator Mendes, Fernanda Rodrigues
Sobral, Karine Marques
Culler, Hebert Fabricio
Couto, Samuel Campanelli Freitas
Pereira, Juliana
Rocha, Vanderson
Martinez, Gracia Aparecida
Lage, Luís Alberto de Pádua Covas
description Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by a hyperinflammatory state and persistent macrophage activation, resulting in reactive phagocytosis of the hematopoietic elements. In children, it is usually a hereditary disorder, while in adults it is usually acquired secondary to viral infections, collagenoses, or tumors. Although accounting for 10% of hematologic malignancies, HLH is rarely associated with multiple myeloma (MM) and other plasmacytic dyscrasias. A 64-year-old Brazilian man seeked medical care with a 3-month history of intermittent fever, weight loss, night sweats, and progressive anemic symptoms. Total blood count showed severe bicytopenia (normocytic-normochromic anemia and thrombocytopenia), biochemical exams showed elevation of creatinine, as well as monoclonal peak in serum protein electrophoresis, high IgA dosage, and serum immunofixation with IgA kappa paraprotein. Bone marrow biopsy showed 30% of monoclonal and phenotypically anomalous plasmocytes, confirming the diagnosis of MM. Diagnosis of HLH was established by the presence of clinical and laboratory criteria: fever, splenomegaly, cytopenias, hypofibrinogenemia, hyperferritinemia, elevation of triglycerides, and several figures of erythrophagocytosis in bone marrow aspirate. The patient experienced pulse therapy with methylprednisolone for hemophagocytic lymphohistiocytosis, followed by initial therapy for multiple myeloma with cyclophosphamide and dexamethasone. Once the diagnosis of MM and secondary hemophagocytic syndrome was established, the patient had a rapid clinical deterioration despite the established therapeutic measures, evolving with cardiovascular failure, acute liver failure, acute disseminated intravascular coagulation, worsening renal dysfunction requiring dialysis support, respiratory dysfunction, and lowering of consciousness, characterizing rapid multiple organ dysfunction, ultimately leading to the death of the patient. Here, we aimed to describe the sixth reported case of HLH associated with MM, according to cases cataloged in the PubMed database, and the first case evaluated by 18-fluordeoxyglucose positron emission tomography (18-FDG-PETCT). Our case report seeks to provide support for a better clinical and laboratory characterization of this rare paraneoplastic entity associated with MM, and aims to call the attention of hematologists and intensivists to this condition that falls within the scope of the differential diagnosis of r
doi_str_mv 10.1097/MD.0000000000022299
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7523830</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32991435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3557-e44f4e66b6098869fef3e414dc5ca605e8e9dea560d471c990ee64df1b46b6473</originalsourceid><addsrcrecordid>eNpdUcluFDEQtRCIDIEvQEL-gQ52extzQBolbFKiXJKz5XFXpw3udmO7M5oD_44nA2GpS0lvK-kVQq8pOaNEq7dXF2fkz7Rtq_UTtKKCyUZoyZ-iVUVFo7TiJ-hFzl8JoUy1_Dk6YVVLORMr9GPjvi8-QYcHGOM82Lvo9sU7HPbjPMTB5-IPSMw-Y5uxn3zxNuDRTr6HXGylJxx7PC6h-DkAHvcQ4mjf4Q12NgNOMMdUsJ06HHyBZMuSDui9h91L9Ky3IcOrX_sU3X78cHP-ubm8_vTlfHPZOCaEaoDznoOUW0n0ei11Dz0DTnnnhLOSCFiD7sAKSTquqNOaAEje9XTLq4crdoreH3PnZTtC52AqyQYzJz_atDfRevMvM_nB3MV7o0TL1ozUAHYMcCnmnKB_9FJiDt8wVxfm_29U15u_zz56ftdfBfwo2MVQq8nfwrKDZAawoQwPeULptmlJS4huBWkqwhT7CWhTmfk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review</title><source>PubMed (Medline)</source><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>IngentaConnect Journals</source><creator>Mendes, Fernanda Rodrigues ; Sobral, Karine Marques ; Culler, Hebert Fabricio ; Couto, Samuel Campanelli Freitas ; Pereira, Juliana ; Rocha, Vanderson ; Martinez, Gracia Aparecida ; Lage, Luís Alberto de Pádua Covas</creator><creatorcontrib>Mendes, Fernanda Rodrigues ; Sobral, Karine Marques ; Culler, Hebert Fabricio ; Couto, Samuel Campanelli Freitas ; Pereira, Juliana ; Rocha, Vanderson ; Martinez, Gracia Aparecida ; Lage, Luís Alberto de Pádua Covas</creatorcontrib><description>Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by a hyperinflammatory state and persistent macrophage activation, resulting in reactive phagocytosis of the hematopoietic elements. In children, it is usually a hereditary disorder, while in adults it is usually acquired secondary to viral infections, collagenoses, or tumors. Although accounting for 10% of hematologic malignancies, HLH is rarely associated with multiple myeloma (MM) and other plasmacytic dyscrasias. A 64-year-old Brazilian man seeked medical care with a 3-month history of intermittent fever, weight loss, night sweats, and progressive anemic symptoms. Total blood count showed severe bicytopenia (normocytic-normochromic anemia and thrombocytopenia), biochemical exams showed elevation of creatinine, as well as monoclonal peak in serum protein electrophoresis, high IgA dosage, and serum immunofixation with IgA kappa paraprotein. Bone marrow biopsy showed 30% of monoclonal and phenotypically anomalous plasmocytes, confirming the diagnosis of MM. Diagnosis of HLH was established by the presence of clinical and laboratory criteria: fever, splenomegaly, cytopenias, hypofibrinogenemia, hyperferritinemia, elevation of triglycerides, and several figures of erythrophagocytosis in bone marrow aspirate. The patient experienced pulse therapy with methylprednisolone for hemophagocytic lymphohistiocytosis, followed by initial therapy for multiple myeloma with cyclophosphamide and dexamethasone. Once the diagnosis of MM and secondary hemophagocytic syndrome was established, the patient had a rapid clinical deterioration despite the established therapeutic measures, evolving with cardiovascular failure, acute liver failure, acute disseminated intravascular coagulation, worsening renal dysfunction requiring dialysis support, respiratory dysfunction, and lowering of consciousness, characterizing rapid multiple organ dysfunction, ultimately leading to the death of the patient. Here, we aimed to describe the sixth reported case of HLH associated with MM, according to cases cataloged in the PubMed database, and the first case evaluated by 18-fluordeoxyglucose positron emission tomography (18-FDG-PETCT). Our case report seeks to provide support for a better clinical and laboratory characterization of this rare paraneoplastic entity associated with MM, and aims to call the attention of hematologists and intensivists to this condition that falls within the scope of the differential diagnosis of rapid onset multiple organ failure in patients with plasmacytic neoplasms.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000022299</identifier><identifier>PMID: 32991435</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Anemia - blood ; Anemia - etiology ; Antineoplastic Agents, Alkylating - administration &amp; dosage ; Antineoplastic Agents, Alkylating - therapeutic use ; Bone Marrow - pathology ; Brazil - epidemiology ; Clinical Case Report ; Cyclophosphamide - administration &amp; dosage ; Cyclophosphamide - therapeutic use ; Dexamethasone - administration &amp; dosage ; Dexamethasone - therapeutic use ; Drug Therapy, Combination ; Fatal Outcome ; Fever - diagnosis ; Fever - etiology ; Glucocorticoids - administration &amp; dosage ; Glucocorticoids - therapeutic use ; Humans ; Lymphohistiocytosis, Hemophagocytic - blood ; Lymphohistiocytosis, Hemophagocytic - diagnosis ; Lymphohistiocytosis, Hemophagocytic - drug therapy ; Lymphohistiocytosis, Hemophagocytic - etiology ; Male ; Methylprednisolone - administration &amp; dosage ; Methylprednisolone - therapeutic use ; Middle Aged ; Multiple Myeloma - complications ; Multiple Myeloma - drug therapy ; Multiple Myeloma - metabolism ; Multiple Organ Failure - complications ; Paraproteinemias - blood ; Plasma Cells - pathology ; Splenomegaly - diagnosis ; Splenomegaly - etiology ; Thrombocytopenia - blood ; Thrombocytopenia - etiology ; Weight Loss</subject><ispartof>Medicine (Baltimore), 2020-09, Vol.99 (39), p.e22299-e22299</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3557-e44f4e66b6098869fef3e414dc5ca605e8e9dea560d471c990ee64df1b46b6473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523830/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523830/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32991435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mendes, Fernanda Rodrigues</creatorcontrib><creatorcontrib>Sobral, Karine Marques</creatorcontrib><creatorcontrib>Culler, Hebert Fabricio</creatorcontrib><creatorcontrib>Couto, Samuel Campanelli Freitas</creatorcontrib><creatorcontrib>Pereira, Juliana</creatorcontrib><creatorcontrib>Rocha, Vanderson</creatorcontrib><creatorcontrib>Martinez, Gracia Aparecida</creatorcontrib><creatorcontrib>Lage, Luís Alberto de Pádua Covas</creatorcontrib><title>Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by a hyperinflammatory state and persistent macrophage activation, resulting in reactive phagocytosis of the hematopoietic elements. In children, it is usually a hereditary disorder, while in adults it is usually acquired secondary to viral infections, collagenoses, or tumors. Although accounting for 10% of hematologic malignancies, HLH is rarely associated with multiple myeloma (MM) and other plasmacytic dyscrasias. A 64-year-old Brazilian man seeked medical care with a 3-month history of intermittent fever, weight loss, night sweats, and progressive anemic symptoms. Total blood count showed severe bicytopenia (normocytic-normochromic anemia and thrombocytopenia), biochemical exams showed elevation of creatinine, as well as monoclonal peak in serum protein electrophoresis, high IgA dosage, and serum immunofixation with IgA kappa paraprotein. Bone marrow biopsy showed 30% of monoclonal and phenotypically anomalous plasmocytes, confirming the diagnosis of MM. Diagnosis of HLH was established by the presence of clinical and laboratory criteria: fever, splenomegaly, cytopenias, hypofibrinogenemia, hyperferritinemia, elevation of triglycerides, and several figures of erythrophagocytosis in bone marrow aspirate. The patient experienced pulse therapy with methylprednisolone for hemophagocytic lymphohistiocytosis, followed by initial therapy for multiple myeloma with cyclophosphamide and dexamethasone. Once the diagnosis of MM and secondary hemophagocytic syndrome was established, the patient had a rapid clinical deterioration despite the established therapeutic measures, evolving with cardiovascular failure, acute liver failure, acute disseminated intravascular coagulation, worsening renal dysfunction requiring dialysis support, respiratory dysfunction, and lowering of consciousness, characterizing rapid multiple organ dysfunction, ultimately leading to the death of the patient. Here, we aimed to describe the sixth reported case of HLH associated with MM, according to cases cataloged in the PubMed database, and the first case evaluated by 18-fluordeoxyglucose positron emission tomography (18-FDG-PETCT). Our case report seeks to provide support for a better clinical and laboratory characterization of this rare paraneoplastic entity associated with MM, and aims to call the attention of hematologists and intensivists to this condition that falls within the scope of the differential diagnosis of rapid onset multiple organ failure in patients with plasmacytic neoplasms.</description><subject>Anemia - blood</subject><subject>Anemia - etiology</subject><subject>Antineoplastic Agents, Alkylating - administration &amp; dosage</subject><subject>Antineoplastic Agents, Alkylating - therapeutic use</subject><subject>Bone Marrow - pathology</subject><subject>Brazil - epidemiology</subject><subject>Clinical Case Report</subject><subject>Cyclophosphamide - administration &amp; dosage</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Dexamethasone - administration &amp; dosage</subject><subject>Dexamethasone - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Fatal Outcome</subject><subject>Fever - diagnosis</subject><subject>Fever - etiology</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Lymphohistiocytosis, Hemophagocytic - blood</subject><subject>Lymphohistiocytosis, Hemophagocytic - diagnosis</subject><subject>Lymphohistiocytosis, Hemophagocytic - drug therapy</subject><subject>Lymphohistiocytosis, Hemophagocytic - etiology</subject><subject>Male</subject><subject>Methylprednisolone - administration &amp; dosage</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - complications</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Multiple Myeloma - metabolism</subject><subject>Multiple Organ Failure - complications</subject><subject>Paraproteinemias - blood</subject><subject>Plasma Cells - pathology</subject><subject>Splenomegaly - diagnosis</subject><subject>Splenomegaly - etiology</subject><subject>Thrombocytopenia - blood</subject><subject>Thrombocytopenia - etiology</subject><subject>Weight Loss</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdUcluFDEQtRCIDIEvQEL-gQ52extzQBolbFKiXJKz5XFXpw3udmO7M5oD_44nA2GpS0lvK-kVQq8pOaNEq7dXF2fkz7Rtq_UTtKKCyUZoyZ-iVUVFo7TiJ-hFzl8JoUy1_Dk6YVVLORMr9GPjvi8-QYcHGOM82Lvo9sU7HPbjPMTB5-IPSMw-Y5uxn3zxNuDRTr6HXGylJxx7PC6h-DkAHvcQ4mjf4Q12NgNOMMdUsJ06HHyBZMuSDui9h91L9Ky3IcOrX_sU3X78cHP-ubm8_vTlfHPZOCaEaoDznoOUW0n0ei11Dz0DTnnnhLOSCFiD7sAKSTquqNOaAEje9XTLq4crdoreH3PnZTtC52AqyQYzJz_atDfRevMvM_nB3MV7o0TL1ozUAHYMcCnmnKB_9FJiDt8wVxfm_29U15u_zz56ftdfBfwo2MVQq8nfwrKDZAawoQwPeULptmlJS4huBWkqwhT7CWhTmfk</recordid><startdate>20200925</startdate><enddate>20200925</enddate><creator>Mendes, Fernanda Rodrigues</creator><creator>Sobral, Karine Marques</creator><creator>Culler, Hebert Fabricio</creator><creator>Couto, Samuel Campanelli Freitas</creator><creator>Pereira, Juliana</creator><creator>Rocha, Vanderson</creator><creator>Martinez, Gracia Aparecida</creator><creator>Lage, Luís Alberto de Pádua Covas</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200925</creationdate><title>Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review</title><author>Mendes, Fernanda Rodrigues ; Sobral, Karine Marques ; Culler, Hebert Fabricio ; Couto, Samuel Campanelli Freitas ; Pereira, Juliana ; Rocha, Vanderson ; Martinez, Gracia Aparecida ; Lage, Luís Alberto de Pádua Covas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3557-e44f4e66b6098869fef3e414dc5ca605e8e9dea560d471c990ee64df1b46b6473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anemia - blood</topic><topic>Anemia - etiology</topic><topic>Antineoplastic Agents, Alkylating - administration &amp; dosage</topic><topic>Antineoplastic Agents, Alkylating - therapeutic use</topic><topic>Bone Marrow - pathology</topic><topic>Brazil - epidemiology</topic><topic>Clinical Case Report</topic><topic>Cyclophosphamide - administration &amp; dosage</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Dexamethasone - administration &amp; dosage</topic><topic>Dexamethasone - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Fatal Outcome</topic><topic>Fever - diagnosis</topic><topic>Fever - etiology</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Lymphohistiocytosis, Hemophagocytic - blood</topic><topic>Lymphohistiocytosis, Hemophagocytic - diagnosis</topic><topic>Lymphohistiocytosis, Hemophagocytic - drug therapy</topic><topic>Lymphohistiocytosis, Hemophagocytic - etiology</topic><topic>Male</topic><topic>Methylprednisolone - administration &amp; dosage</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - complications</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Multiple Myeloma - metabolism</topic><topic>Multiple Organ Failure - complications</topic><topic>Paraproteinemias - blood</topic><topic>Plasma Cells - pathology</topic><topic>Splenomegaly - diagnosis</topic><topic>Splenomegaly - etiology</topic><topic>Thrombocytopenia - blood</topic><topic>Thrombocytopenia - etiology</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mendes, Fernanda Rodrigues</creatorcontrib><creatorcontrib>Sobral, Karine Marques</creatorcontrib><creatorcontrib>Culler, Hebert Fabricio</creatorcontrib><creatorcontrib>Couto, Samuel Campanelli Freitas</creatorcontrib><creatorcontrib>Pereira, Juliana</creatorcontrib><creatorcontrib>Rocha, Vanderson</creatorcontrib><creatorcontrib>Martinez, Gracia Aparecida</creatorcontrib><creatorcontrib>Lage, Luís Alberto de Pádua Covas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mendes, Fernanda Rodrigues</au><au>Sobral, Karine Marques</au><au>Culler, Hebert Fabricio</au><au>Couto, Samuel Campanelli Freitas</au><au>Pereira, Juliana</au><au>Rocha, Vanderson</au><au>Martinez, Gracia Aparecida</au><au>Lage, Luís Alberto de Pádua Covas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2020-09-25</date><risdate>2020</risdate><volume>99</volume><issue>39</issue><spage>e22299</spage><epage>e22299</epage><pages>e22299-e22299</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by a hyperinflammatory state and persistent macrophage activation, resulting in reactive phagocytosis of the hematopoietic elements. In children, it is usually a hereditary disorder, while in adults it is usually acquired secondary to viral infections, collagenoses, or tumors. Although accounting for 10% of hematologic malignancies, HLH is rarely associated with multiple myeloma (MM) and other plasmacytic dyscrasias. A 64-year-old Brazilian man seeked medical care with a 3-month history of intermittent fever, weight loss, night sweats, and progressive anemic symptoms. Total blood count showed severe bicytopenia (normocytic-normochromic anemia and thrombocytopenia), biochemical exams showed elevation of creatinine, as well as monoclonal peak in serum protein electrophoresis, high IgA dosage, and serum immunofixation with IgA kappa paraprotein. Bone marrow biopsy showed 30% of monoclonal and phenotypically anomalous plasmocytes, confirming the diagnosis of MM. Diagnosis of HLH was established by the presence of clinical and laboratory criteria: fever, splenomegaly, cytopenias, hypofibrinogenemia, hyperferritinemia, elevation of triglycerides, and several figures of erythrophagocytosis in bone marrow aspirate. The patient experienced pulse therapy with methylprednisolone for hemophagocytic lymphohistiocytosis, followed by initial therapy for multiple myeloma with cyclophosphamide and dexamethasone. Once the diagnosis of MM and secondary hemophagocytic syndrome was established, the patient had a rapid clinical deterioration despite the established therapeutic measures, evolving with cardiovascular failure, acute liver failure, acute disseminated intravascular coagulation, worsening renal dysfunction requiring dialysis support, respiratory dysfunction, and lowering of consciousness, characterizing rapid multiple organ dysfunction, ultimately leading to the death of the patient. Here, we aimed to describe the sixth reported case of HLH associated with MM, according to cases cataloged in the PubMed database, and the first case evaluated by 18-fluordeoxyglucose positron emission tomography (18-FDG-PETCT). Our case report seeks to provide support for a better clinical and laboratory characterization of this rare paraneoplastic entity associated with MM, and aims to call the attention of hematologists and intensivists to this condition that falls within the scope of the differential diagnosis of rapid onset multiple organ failure in patients with plasmacytic neoplasms.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>32991435</pmid><doi>10.1097/MD.0000000000022299</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2020-09, Vol.99 (39), p.e22299-e22299
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7523830
source PubMed (Medline); HEAL-Link subscriptions: Lippincott Williams & Wilkins; IngentaConnect Journals
subjects Anemia - blood
Anemia - etiology
Antineoplastic Agents, Alkylating - administration & dosage
Antineoplastic Agents, Alkylating - therapeutic use
Bone Marrow - pathology
Brazil - epidemiology
Clinical Case Report
Cyclophosphamide - administration & dosage
Cyclophosphamide - therapeutic use
Dexamethasone - administration & dosage
Dexamethasone - therapeutic use
Drug Therapy, Combination
Fatal Outcome
Fever - diagnosis
Fever - etiology
Glucocorticoids - administration & dosage
Glucocorticoids - therapeutic use
Humans
Lymphohistiocytosis, Hemophagocytic - blood
Lymphohistiocytosis, Hemophagocytic - diagnosis
Lymphohistiocytosis, Hemophagocytic - drug therapy
Lymphohistiocytosis, Hemophagocytic - etiology
Male
Methylprednisolone - administration & dosage
Methylprednisolone - therapeutic use
Middle Aged
Multiple Myeloma - complications
Multiple Myeloma - drug therapy
Multiple Myeloma - metabolism
Multiple Organ Failure - complications
Paraproteinemias - blood
Plasma Cells - pathology
Splenomegaly - diagnosis
Splenomegaly - etiology
Thrombocytopenia - blood
Thrombocytopenia - etiology
Weight Loss
title Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A09%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acquired%20hemophagocytic%20lymphohistiocytosis%20as%20initial%20manifestation%20of%20multiple%20myeloma:%20A%20case%20report%20and%20literature%20review&rft.jtitle=Medicine%20(Baltimore)&rft.au=Mendes,%20Fernanda%20Rodrigues&rft.date=2020-09-25&rft.volume=99&rft.issue=39&rft.spage=e22299&rft.epage=e22299&rft.pages=e22299-e22299&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000022299&rft_dat=%3Cpubmed_cross%3E32991435%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3557-e44f4e66b6098869fef3e414dc5ca605e8e9dea560d471c990ee64df1b46b6473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32991435&rfr_iscdi=true